BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Lee A, Cohen MA, Sherman EJ, Lee NY. Past, present and future of proton therapy for head and neck cancer. Oral Oncol 2020;110:104879. [PMID: 32650256 DOI: 10.1016/j.oraloncology.2020.104879] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao H, Wang F, Wang X, Zhao X, Ji J. HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/7357566] [Reference Citation Analysis]
2 de Jong BA, Battinelli C, Free J, Wagenaar D, Engwall E, Janssens G, Langendijk JA, Korevaar EW, Both S. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients. Med Phys 2022. [PMID: 36373893 DOI: 10.1002/mp.16098] [Reference Citation Analysis]
3 Udalov YD, Nezvetsky AV, Danilova LA, Kiselev VA, Kovalenko LO, Kozlova IV, Gritsenko SE. Analysis of the Results of Proton Radiation Therapy of Patients with Squamous Cell Carcinoma of the Head and Neck. jour 2022;5:9-17. [DOI: 10.37174/2587-7593-2022-5-3-9-17] [Reference Citation Analysis]
4 Demurtas S, Ingargiola R, Orlandi E, Locati LD. How can we address the challenge of distant metastases in HNSCC prognosis? Expert Rev Anticancer Ther 2022. [PMID: 35786143 DOI: 10.1080/14737140.2022.2096008] [Reference Citation Analysis]
5 Liu C, Huang B, Lin C, Yeh C, Lee T, Wu H, Chang C, Chang T, Huang K, Jiang J, Chang JT, Chang Y. Head and Neck Cancer Types and Risks of Cervical–Cranial Vascular Complications within 5 Years after Radiation Therapy. JPM 2022;12:1060. [DOI: 10.3390/jpm12071060] [Reference Citation Analysis]
6 Zhu Y, Zheng S, Zhai X, Wang C, Liu A, Ju J, Peng X, Chen L, Zhang Y, Ren N, Xie Y, Fan J, Zhao K, Liu M, Zhuo Z. Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/5501476] [Reference Citation Analysis]
7 Campbell G, Glazer TA, Kimple RJ, Bruce JY. Advances in Organ Preservation for Laryngeal Cancer. Curr Treat Options Oncol 2022. [PMID: 35303749 DOI: 10.1007/s11864-022-00945-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lee DW, Kim JE, Lee GH, Son A, Park HC, Oh D, Jo K, Choi C. High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations. Int J Mol Sci 2022;23:587. [PMID: 35054773 DOI: 10.3390/ijms23020587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Leach K, Tang S, Sturgeon J, Lee AK, Grover R, Sanghvi P, Urbanic J, Chang C. Beam-Specific Spot Guidance and Optimization for PBS Proton Treatment of Bilateral Head and Neck Cancers. Int J Part Ther 2021;8:50-61. [PMID: 34285935 DOI: 10.14338/IJPT-20-00060.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Li X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, Dunn LA, Michel LS, Fetten J, Zakeri K, Yu Y, Chen L, Kang JJ, Gelblum DY, McBride SM, Tsai CJ, Riaz N, Lee NY. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. JAMA Netw Open 2021;4:e2113205. [PMID: 34143193 DOI: 10.1001/jamanetworkopen.2021.13205] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
11 Oh D. Proton Therapy for Head and Neck Cancer: Current Clinical Applications and Future Direction. Korean J Head Neck Oncol 2021;37:1-10. [DOI: 10.21593/kjhno/2021.37.1.1] [Reference Citation Analysis]